Latest Post
Cornerstone Robotics, a pioneer in surgical robotics, announced on January 13, 2025, that it has raised over $70 million in Series C funding.
The round was led by EQT, with participation from prominent investors including Qiming Venture Partners, Alpha JWC Ventures, the Innovation and Technology Venture Fund, eGarden Ventures, CTS Funds, K2VC, and Long-Z Capital. This substantial investment underscores the growing confidence in Cornerstone Robotics’ mission to revolutionize healthcare by making advanced surgical systems globally accessible.
Funding Details and Investor Participation
EQT is one of the premier global investment organisations known for nurturing innovative companies particularly in the healthcare and technology sectors, leading the financing round of C. Clara Ho and Gordon Shaw, Partners, in the Advisory Team for Private Capital Asia also voiced their encouragement: “We are proud of Cornerstone Robotics for leading from the front when it comes to this kind of cutting edge medical robotics into access for those who need these kinds of access.”
Other notable investors in the round include Qiming Venture Partners, which is a venture capital firm that invests heavily in healthcare and technology. William Hu, Managing Partner at Qiming Venture Partners said, “We believe Cornerstone Robotics is well-positioned to deliver increasingly competitive products and greater clinical value to customers worldwide.”
Alpha JWC Ventures, an Indonesia-based venture capital firm, also participated in the round, which shows the strategic significance of Southeast Asia in Cornerstone Robotics’ expansion plans. According to Jefrey Joe, General Partner at Alpha JWC Ventures, “We are committed to supporting their growth and success to bring the highest standards of healthcare in the region.
Read also: Serve Robotics a autonomous delivery company, raised $86M funding
Strategic Objectives Post-Funding
Infusion of over $70 million to significantly push the strategic initiatives for Cornerstone Robotics into the next stage, which will include the following:
- Commercialization: To bring their innovative surgical robotics products faster to market. This way, advanced surgical solutions will reach more patients.
- Product Development: Further research and development of new technologies in surgical robotics for the improvement and expansion of capabilities and applications for their product line.
- Clinical Trials and Regulatory Approvals: Conducts extensive clinical studies to ensure and validate the product’s safety and efficacy, seeking necessary regulatory approval to enter newer markets.
- Geo Expansion: Increases adoption of new robotic surgical applications across key geography, including in Europe, southeast Asia, and rest of the geographic markets.
Investment in Invention and Technologies Venture Fund
Apart from private investment, Cornerstone Robotics received investments from the Innovation and Technology Venture Fund under the Innovation and Technology Commission of the Hong Kong Special Administrative Region Government. Such endorsements reflect governmental confidence in the company’s product innovation as well as their global commercialization capabilities, making it easier for expansion into crucial international markets.
Company Background and Milestones
Cornerstone Robotics was founded in September 2019 and is headquartered in both Hong Kong and the Greater Bay Area. The company has fast-tracked itself as a leader in the surgical robotics industry through focusing on in-house research and development coupled with a vertically integrated supply chain.
This enables it to produce high-performance surgical systems at competitive prices. This has enabled collaborations with top medical institutions in mainland China, Hong Kong, and Europe, such as the Faculty of Medicine of the Chinese University of Hong Kong and Chinese University of Hong Kong-Shenzhen Medicine.
September 2024, Cornerstone Robotics marked one milestone by finally obtaining approval in “Sentire”, China’s first-of-its kind Endoscopic Surgical System developed by the firm for the use in China through NMPA or National Medical Products Administration, for the critical aim of getting it to most countries around the globe.
Read also: Xocean an Irish marine robotics startup has raised $119M funding
Globalization Initiative
Cornerstone Robotics has expanded its international footprint by opening a site in the United Kingdom in 2024. This is in line with its strategy to facilitate cutting-edge innovation, support advanced research, and improve the ability of the company to serve patients in Europe and other global markets.
Leadership Perspective
Professor Samuel Au, founder and CEO of Cornerstone Robotics, said: “We have been able to achieve independent R&D and manufacturing, and even gained recognition from the NMPA in 2024, within five years of hard work. The next step will be to continually innovate, expanding the global market, advancing international certifications, and working with more partners to create value for the intelligent healthcare industry and contribute to a better future for humanity.”
Summary
Hong Kong-based Cornerstone Robotics has successfully raised over $70 million in a Series C financing round. This significant investment is set to accelerate the company’s research and development, commercialization efforts, and international expansion, aiming to make advanced robotic surgical solutions more accessible worldwide.
